Categories: Press Releases

Medical Terminology Software Market: Global Outlook (2024–2034)

The global medical terminology software market is valued at USD 1.17 billion in 2024, rising to USD 1.3 billion in 2025, and is projected to reach USD 3.34 billion by 2034, growing at a CAGR of 10.94%.

Get All the Details in Our Solutions – Download Brochure: https://www.towardshealthcare.com/download-brochure/5551

Key Market Highlights

  • North America led the global market in 2024, while Asia-Pacific is forecasted to grow at the fastest pace.
  • Quality reporting was the top application segment in 2024, followed by strong growth expected in the reimbursement segment.
  • Healthcare providers dominated the end-user category, with healthcare payers expected to witness notable growth.

Market Drivers

  • Surge in clinical trials driving software usage in planning, data collection, and regulatory compliance.
  • Rising adoption of EHR systems, promoting seamless data entry and standardized communication.
  • Advancements in AI and NLP, improving software efficiency and enhancing real-time data processing.

Challenges

  • High implementation costs are a barrier, especially for low- and middle-income healthcare organizations.

Opportunities

  • Rapid digitization of healthcare systems worldwide.
  • Government support and incentives for IT adoption in healthcare.
  • AI and ML integration for better accuracy, compliance, and decision-making.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Regional Trends

  • United States: Supported by federal investments and high healthcare IT adoption.
  • Canada: Utilizes MedDRA for regulatory activities; backed by $2.1B+ government investment in HIT.
  • Asia-Pacific: Fastest-growing region, led by China and India due to increasing clinical trials, digital health missions, and rising health awareness.
  • Europe: Investments under the RRF (€14 billion) and national initiatives like Germany’s Medical Informatics Initiative are fueling market growth.

Recent Industry Developments

  • Corti launched a specialized Dictation API (April 2025) to democratize healthcare dictation technology.
  • AWS introduced HealthScribe (July 2023), simplifying patient-physician documentation and terminology understanding.
  • Vital launched an AI-based Doctor-to-Patient Translator using NLP for 5th-grade level medical explanations.

Top Companies

  • 3M
  • Wolters Kluwer Health
  • Intelligent Medical Objects
  • Cerner Corp
  • Amazon Web Services
  • Athena Health
  • Corti
  • Vital
  • eClinicalWorks
  • Clinical Architecture, LLC
  • Hiveworx
  • inVerita
  • B2i Healthcare

Segmentation Overview

By Application

  • Quality Reporting
  • Reimbursement
  • Data Aggregation
  • Clinical Trials
  • Others

By End-User

  • Healthcare Providers
  • Healthcare Payers
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, UK, France, etc.)
  • Asia-Pacific (China, India, Japan, etc.)
  • Latin America (Brazil, Mexico, Argentina)
  • MEA (UAE, South Africa, Saudi Arabia)

To invest in our premium strategic solution and customized market report options, click here:  https://www.towardshealthcare.com/price/5551 

sanskruti sathe

Recent Posts

Kedrion Biopharma’s COAGADEX® Receives FDA Orphan Drug Designation for Acquired Factor X Deficiency (AFXD)

Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More

18 hours ago

Benecard PBF and DecisionRX Join Forces to Personalize and Optimize Pharmacy Benefits

enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More

18 hours ago

Four Resilient Biotech Companies Making Waves in a Challenging Market

In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More

18 hours ago

Natera Launches TEODOR Trial in Partnership with ABCSG to Advance Personalized Breast Cancer Treatment

cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More

18 hours ago

Interventional Radiology Market: Size, Growth, and Leading Companies Driving Innovation

The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More

23 hours ago

Physical Therapy Market Growth and Leading Companies Driving Innovation

The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More

23 hours ago